Subodh Verma
Subodh Verma is a prominent cardiac surgeon and scientist at St. Michael’s Hospital in Toronto, recognized for his research on the complications of diabetes, especially peripheral artery disease (PAD). He co-led a significant clinical trial demonstrating the benefits of semaglutide for patients suffering from PAD, emphasizing the drug's role as a disease-modifying therapy that can improve walking ability and quality of life in diabetic patients.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 7.00 | 0.07% | +0% | 38,005,238 | 27,966 | $1,700,000 | 1,251$ |
| Totals | 1 | 38,005,238 | 27,966 | $1,700,000 | 1,251$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Subodh Verma is a cardiac surgeon and scientist at St. Michael’s Hospital who co-led the SELECT trial.
7
Canada:
Subodh Verma is a cardiac surgeon and scientist at St. Michael’s who co-led the international trial on semaglutide.
9